<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261003071279N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-08</date_registration>
      <primary_sponsor>Islamic Azad University, Isfahan (Khorasgan) Branch</primary_sponsor>
      <public_title>Effect of Brief Solution-Focused Therapy on Aggression, Interpersonal Sensitivity, Problem-Solving Ability, and Social Skills in Adolescents</public_title>
      <acronym></acronym>
      <scientific_title>The Effectiveness of Short-Term Solution-Focused Therapy on Aggressive Behaviors, Interpersonal Sensitivity, Problem-Solving Ability, and Social Skills in Female High School Adolescents</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/93808</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: After selecting 30 eligible students, a numerical code ranging from 1 to 30 is assigned to each participant. Using a table of random numbers, a starting point is randomly selected, and the numbers in the table are examined sequentially from that point in a specific direction. Numbers corresponding to the participants' codes are extracted in order—without repetition—to form a randomized list of the 30 participants. The first 15 codes are assigned to the experimental group, and the subsequent 15 codes are assigned to the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Aggression. Condition 2: Interpersonal sensitivity. Condition 3: Problem-solving ability. Condition 4: Social skills.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Brief Solution-Focused Therapy is delivered in a group format over 8 weekly sessions, with each session lasting 60 minutes.Session 1: Establishing the therapeutic relationship and readiness for change. Participants become familiar with each other and the session framework. The goals, rules, and procedures of the sessions are explained, with emphasis on participants’ strengths and the possibility of change.Session 2: Introduction to the solution-focused therapy framework. The basic principles of the solution-focused approach and the active role of the client in the change process are introduced. Patterns related to problem maintenance and ineffective solutions are also explored.Session 3: Identifying successful experiences and effective strategies. Participants identify situations in which they have responded effectively to difficult circumstances, extract effective strategies, and focus on reusing successful responses.Session 4: Hope and commitment to change. Small and achievable changes are emphasized. Participants discuss their preferred situation, existing barriers, and possible steps toward change. Scaling questions are used to assess the current situation and progress.Session 5: Identifying resources and exceptions. Participants identify situations in which the problem is less severe or functioning is more desirable. Personal resources and successful experiences are explored, along with ways to use them in similar situations.Session 6: Visualizing the preferred future and finding solutions. The miracle question is used to help participants imagine their preferred situation. Expected changes in thoughts, emotions, and behaviors are explored, and different constructive ways of moving toward the preferred situation are identified.Session 7: Moving toward goals and consolidating change. Participants review changes and steps taken toward their goals, focus on small and observable changes, and identify and strengthen new and effective patterns.Session 8: Reviewing and evaluating changes and termination. Initial goals and progress are reviewed. Changes and individual achievements are examined, progress is assessed using scaling questions, participants’ participation is acknowledged, and the therapy process is summarized and concluded. Intervention 2: Control group: The control group does not receive Brief Solution-Focused Therapy during the intervention period and continues its usual educational activities.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Individual participant data are used solely for statistical analysis within the scope of the research objectives and questions; given the nature and aims of the study, sharing the individual data file is not necessary to achieve the research objectives.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arefeh Asgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>East Jay Street, Arghavaniyeh, Daneshgah Boulevard</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>39998-81551</zip>
        <telephone>+98 31 3500 2000</telephone>
        <email>aasgariasgari1@gmail.com</email>
        <affiliation>Islamic Azad University, Isfahan (Khorasgan) Branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sara Javadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>East Jay Street, Arghavaniyeh, Daneshgah Boulevard</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8155139998</zip>
        <telephone>+98 31 3500 2000</telephone>
        <email>info@khuisf.ac.ir</email>
        <affiliation>Islamic Azad University, Isfahan (Khorasgan) Branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Must be a female student in the 10th, 11th, or 12th grade of upper secondary school.
Informed consent for participation in the research must be obtained from the student and their parents.
Must not have any physical or cognitive impairment, or acute mental disorder, that prevents participation in the research.</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>18 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Simultaneously participate in a counseling session or a related skills workshop.
Voluntarily withdraw from further participation in the research.
Do not fail to complete the between-session assignments and exercises more than twice.
Absence exceeding two sessions
her environmental or living conditions change in a way that disrupts the continuation of the intervention.
Physical or family circumstances prevent her from continuing her participation.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Brief Solution-Focused Therapy is delivered in a group format over 8 weekly sessions, with each session lasting 60 minutes.Session 1: Establishing the therapeutic relationship and readiness for change. Participants become familiar with each other and the session framework. The goals, rules, and procedures of the sessions are explained, with emphasis on participants’ strengths and the possibility of change.Session 2: Introduction to the solution-focused therapy framework. The basic principles of the solution-focused approach and the active role of the client in the change process are introduced. Patterns related to problem maintenance and ineffective solutions are also explored.Session 3: Identifying successful experiences and effective strategies. Participants identify situations in which they have responded effectively to difficult circumstances, extract effective strategies, and focus on reusing successful responses.Session 4: Hope and commitment to change. Small and achievable changes are emphasized. Participants discuss their preferred situation, existing barriers, and possible steps toward change. Scaling questions are used to assess the current situation and progress.Session 5: Identifying resources and exceptions. Participants identify situations in which the problem is less severe or functioning is more desirable. Personal resources and successful experiences are explored, along with ways to use them in similar situations.Session 6: Visualizing the preferred future and finding solutions. The miracle question is used to help participants imagine their preferred situation. Expected changes in thoughts, emotions, and behaviors are explored, and different constructive ways of moving toward the preferred situation are identified.Session 7: Moving toward goals and consolidating change. Participants review changes and steps taken toward their goals, focus on small and observable changes, and identify and strengthen new and effective patterns.Session 8: Reviewing and evaluating changes and termination. Initial goals and progress are reviewed. Changes and individual achievements are examined, progress is assessed using scaling questions, participants’ participation is acknowledged, and the therapy process is summarized and concluded.</i_keyword>
      <i_keyword>Control group: The control group does not receive Brief Solution-Focused Therapy during the intervention period and continues its usual educational activities.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Aggression: scores on the Buss and Perry Aggression Questionnaire at pre-test and post-test; Interpersonal Sensitivity: scores on the Boyce and Parker Interpersonal Sensitivity Index  at pre-test and post-test; Problem-Solving Ability: scores on the Heppner Problem-Solving Questionnaire at pre-test and post-test; Social Skills: scores on the Inderbitzen and Foster Adolescent Social Skills Scale at pre-test and post-test. Timepoint: Pretest, before the intervention; posttest, immediately after completion of the 8-session intervention. Method of measurement: 1. Buss and Perry Aggression Questionnaire, developed by Buss and Perry in 1992, consists of 29 items assessing four subscales: physical aggression, verbal aggression, anger, and hostility.2. Boyce and Parker Interpersonal Sensitivity Measure, developed by Boyce and Parker in 1989, consists of 38 items.3. Heppner and Petersen Problem-Solving Inventory, developed by Heppner and Petersen in 1982, consists of 32 items.4. Inderbitzen and Foster Teenage Inventory of Social Skills, developed by Inderbitzen and Foster in 1992, originally consists of 40 items. In the present study, item 22 was removed, and 39 items were used.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University, Isfahan (Khorasgan) Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-05</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Isfahan (Khorasgan) Branch</contact_name>
        <contact_address>East Jay Street, Arghavaniyeh, Daneshgah Boulevard Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
